Clinical Trial Update: Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the optimum delivery route for botulinum toxin A in patients with epiphora has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epiphora

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Merbs, Shannath, M.D., Ph.D. | Conditions: Epiphora | Phase 2 | Status: COMPLETED